These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1531741)

  • 1. Antiemetic or antinauseant effect of ondansetron?
    Dundee JW; McMillan CM
    Anesth Analg; 1992 Mar; 74(3):473-4. PubMed ID: 1531741
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ondansetron against nausea and vomiting caused by dacarbazine-containing chemotherapy.
    Legha SS; Hodges C; Ring S
    Cancer; 1992 Oct; 70(7):2018-20. PubMed ID: 1388090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist.
    Leeser J; Lip H
    Anesth Analg; 1991 Jun; 72(6):751-5. PubMed ID: 1827966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy.
    Sagar SM; Bayliss MA; Chong SL; Retsas S
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):183. PubMed ID: 1829958
    [No Abstract]   [Full Text] [Related]  

  • 5. Ondansetron for patients given abdominal radiotherapy.
    Rosenthal SA; Marquez CM; Hourigan HP; Ryu JK
    Lancet; 1992 Feb; 339(8791):490. PubMed ID: 1346837
    [No Abstract]   [Full Text] [Related]  

  • 6. Ondansetron. Therapeutic use as an antiemetic.
    Milne RJ; Heel RC
    Drugs; 1991 Apr; 41(4):574-95. PubMed ID: 1711961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis.
    Rosso R; Campora E; Cetto G; Fosser V; Marangolo M; Oliva C
    Anticancer Res; 1991; 11(2):937-9. PubMed ID: 1829602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron is effective in decreasing postoperative nausea and vomiting.
    Dershwitz M; Rosow CE; Di Biase PM; Joslyn AF; Sanderson PE
    Clin Pharmacol Ther; 1992 Jul; 52(1):96-101. PubMed ID: 1385567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron in the control of refractory emesis following radiotherapy.
    Roberts JT
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):67-8. PubMed ID: 1531294
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.
    Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL
    N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making chemotherapy easier.
    Grunberg SM
    N Engl J Med; 1990 Mar; 322(12):846-8. PubMed ID: 2137903
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of carboplatin induced emesis by ondansetron.
    Harvey VJ; Evans BD; Mitchell PL; Mak D; Neave LM; Langley GB; Dickson DS
    Br J Cancer; 1991 Jun; 63(6):942-4. PubMed ID: 1829954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.
    Marty M
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S41-5. PubMed ID: 2533898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Smith DB; Newlands ES; Rustin GJ; Begent RH; Howells N; McQuade B; Bagshawe KD
    Lancet; 1991 Aug; 338(8765):487-90. PubMed ID: 1714532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.
    Pinkerton CR; Williams D; Wootton C; Meller ST; McElwain TJ
    Arch Dis Child; 1990 Aug; 65(8):822-5. PubMed ID: 2144721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic activity of ondansetron in cancer patients receiving non-cisplatin chemotherapy.
    Fraschini G
    Semin Oncol; 1992 Aug; 19(4 Suppl 10):41-7. PubMed ID: 1387249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.
    Larijani GE; Gratz I; Afshar M; Minassian S
    Anesth Analg; 1991 Sep; 73(3):246-9. PubMed ID: 1831015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
    Smith DB; Newlands ES; Spruyt OW; Begent RH; Rustin GJ; Mellor B; Bagshawe KD
    Br J Cancer; 1990 Feb; 61(2):323-4. PubMed ID: 2138031
    [No Abstract]   [Full Text] [Related]  

  • 19. Ondansetron--the first of a new class of antiemetic agents.
    Chaffee BJ; Tankanow RM
    Clin Pharm; 1991 Jun; 10(6):430-46. PubMed ID: 1829668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.